Correlations of inflammatory biomarkers with the onset and prognosis of idiopathic sudden sensorineural hearing loss

Otology and Neurotology

Volumn 33, Issue 7, 2012, Pages 1142-1150

  Masuda, Masatsugu ^a   Kanzaki, Sho ^a   Minami, Shujiro ^a   Kikuchi, Jun ^b   Kanzaki, Jin ^a   Sato, Hiroaki ^b   Ogawa, Kaoru ^a  

^a KEIO UNIVERSITY   (Japan)

^b IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Idiopathic sensorineural hearing loss; Natural killer cell; Neutrophil; Stress response theory

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD; FEMALE; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MALE; MIDDLE AGED; NATURAL KILLER CELL; PERCEPTION DEAFNESS; PROGNOSIS; SEVERITY OF ILLNESS INDEX; SUDDEN DEAFNESS;

ADULT; AGED; BIOLOGICAL MARKERS; FEMALE; HEARING LOSS, SENSORINEURAL; HEARING LOSS, SUDDEN; HUMANS; INFLAMMATION; INTERLEUKIN-6; KILLER CELLS, NATURAL; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PROGNOSIS; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84865610566     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/MAO.0b013e3182635417     Document Type: Article

References (67)

1. Merchant SN, Durand ML, Adams JC. Sudden deafness: is it viral? ORL J Otorhinolaryngol Relat Spec 2008;70:52-60.
2. Quaranta N, Ramunni A, Brescia P, et al. Soluble intercellular adhesion molecule 1 and soluble vascular cell adhesion molecule 1 in sudden hearing loss. Otol Neurotol 2008;29:470-4.
3. Ryan AF, Harris JP, Keithley EM. Immune-mediated hearing loss: basic mechanisms and options for therapy. Acta Otolaryngol Suppl 2002;38-43.
4. Merchant SN, Adams JC, Nadol JB Jr. Pathology and pathophysiology of idiopathic sudden sensorineural hearing loss. Otol Neurotol 2005;26:151-60.
5. Adams JC, Seed B, Lu N, et al. Selective activation of nuclear factor kappa B in the cochlea by sensory and inflammatory stress. Neuroscience 2009;160:530-9.
6. Adams JC. Clinical implications of inflammatory cytokines in the cochlea: a technical note. Otol Neurotol 2002;23:316-22.
7. Masuda M, Nagashima R, Kanzaki S, et al. Nuclear factor-kappa B nuclear translocation in the cochlea of mice following acoustic overstimulation. Brain Res 2006;1068:237-47.
8. Fujioka M, Kanzaki S, Okano HJ, et al. Proinflammatory cytokines expression in noise-induced damaged cochlea. J Neurosci Res 2006; 83:575-83.
9. WakabayashiK,FujiokaM,KanzakiS, et al. Blockade of interleukin-6 signaling suppressed cochlear inflammatory response and improved hearing impairment in noise-damaged mice cochlea. Neurosci Res 2010;66:345-52.
10. Iliopoulos D, Jaeger SA, Hirsch HA, et al. STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol Cell 2010;39: 493-506.
11. Ahn KS, Aggarwal BB. Transcription factor NF-kappaB: a sensor for smoke and stress signals. Ann N Y Acad Sci 2005;1056:218-33.
12. Jeong HJ, Hong SH, Park RK, et al. Hypoxia-induced IL-6 production is associated with activation of MAP kinase, HIF-1, and NF-kappaB on HEI-OC1 cells. Hear Res 2005;207:59-67.
13. Dhabhar FS. Stress, leukocyte trafficking, and the augmentation of skin immune function. Ann N Y Acad Sci 2003;992:205-17.
14. Dhabhar FS. Enhancing versus suppressive effects of stress on immune function: implications for immunoprotection and immunopathology. Neuroimmunomodulation 2009;16:300-17.
15. Buck BH, Liebeskind DS, Saver JL, et al. Early neutrophilia is associated with volume of ischemic tissue in acute stroke. Stroke 2008;39:355-60.
16. Ovbiagele B, Lynn MJ, Saver JL, et al. Leukocyte count and vascular risk in symptomatic intracranial atherosclerosis. Cerebrovasc Dis 2007;24:283-8.
17. Khuseyinova N, Koenig W. Biomarkers of outcome from cardiovascular disease. Curr Opin Crit Care 2006;12:412-9.
18. Maugeri N, Manfredi AA, Maseri A. Clinical and experimental evidences on the prothrombotic properties of neutrophils. Srp Arh Celok Lek 2010;138:50-2.
19. Ridker PM. Inflammatory biomarkers and risks of myocardial infarction, stroke, diabetes, and total mortality: implications for longevity. Nutr Rev 2007;65:S253-9.
20. Hoshi T, Kitagawa K, Yamagami H, et al. Relations of serum highsensitivity C-reactive protein and interleukin-6 levels with silent brain infarction. Stroke 2005;36:768-72.
21. Nijm J, Wikby A, Tompa A, et al. Circulating levels of proinflammatory cytokines and neutrophil-platelet aggregates in patients with coronary artery disease. Am J Cardiol 2005;95:452-6.
22. Arslan N, Oguz H, Demirci M, et al. Combined intratympanic and systemic use of steroids for idiopathic sudden sensorineural hearing loss. Otol Neurotol 2011;32:393-7.
23. Suzuki H, Mori T, Hashida K, et al. Prediction model for hearing outcome in patients with idiopathic sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol 2011;268:497-500.
24. Chau JK, Lin JR, Atashband S, et al. Systematic review of the evidence for the etiology of adult sudden sensorineural hearing loss. Laryngoscope 2010;120:1011-21.
25. Ceylan A, Celenk F, Kemaloglu YK, et al. Impact of prognostic factors on recovery from sudden hearing loss. J Laryngol Otol 2007; 121:1035-40.
26. Kanzaki J, Taiji H, Ogawa K. Evaluation of hearing recovery and efficacy of steroid treatment in sudden deafness. Acta Otolaryngol Suppl 1988;456:31-6.
27. von Vietinghoff S, Ley K. Homeostatic regulation of blood neutrophil counts. J Immunol 2008;181:5183-8.
28. Goldberg DP, Hillier VF. A scaled version of the General Health Questionnaire. Psychol Med 1979;9:139-45.
29. Iwata N, Saito K. The factor structure of the 28-item General Health Questionnaire when used in Japanese early adolescents and adult employees: age- and cross-cultural comparisons. Eur Arch Psychiatry Clin Neurosci 1992;242:172-8.
30. Tsuboi H, Kawamura N, Hori R, et al. Depressive symptoms and life satisfaction in elderly women are associated with natural killer cell number and cytotoxicity. Int J Behav Med 2005;12:236-43.
31. Sugiura M, Naganawa S, Teranishi M, et al. Three-dimensional fluid-attenuated inversion recovery magnetic resonance imaging findings in patients with sudden sensorineural hearing loss. Laryngoscope 2006;116:1451-4.
32. Green MR, Kennell AS, Larche MJ, et al. Natural killer cell activity in families of patients with systemic lupus erythematosus: demonstration of a killing defect in patients. Clin Exp Immunol 2005; 141:165-73.
33. Sporri R, Joller N, Hilbi H, et al. A novel role for neutrophils as critical activators of NK cells. J Immunol 2008;181:7121-30.
34. Costantini C, Micheletti A, Calzetti F, et al. Neutrophil activation and survival are modulated by interaction with NK cells. Int Immunol 2010;22:827-38.
35. Shi FD, Ljunggren HG, Sarvetnick N. Innate immunity and autoimmunity: from self-protection to self-destruction. Trends Immunol 2001;22:97-101.
36. King PT, Ngui J, Farmer MW, et al. Cytotoxic T lymphocyte and natural killer cell responses to non-typeable Haemophilus influenzae. Clin Exp Immunol 2008;152:542-51.
37. Borella P, Bargellini A, Rovesti S, et al. Emotional stability, anxiety, and natural killer activity under examination stress. Psychoneuroendocrinology 1999;24:613-27.
38. Boscolo P, Di Donato A, Di Giampaolo L, et al. Blood natural killer activity is reduced in men with occupational stress and job insecurity working in a university. Int Arch Occup Environ Health 2009;82:787-94.
39. Fletcher MA, Zeng XR, Maher K, et al. Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26. PLoS One 2010;5:e10817.
40. Cohen F, Kemeny ME, Zegans LS, et al. Immune function declines with unemployment and recovers after stressor termination. Psychosom Med 2007;69:225-34.
41. Fondell E, Axelsson J, Franck K, et al. Short natural sleep is associated with higher T cell and lower NK cell activities. Brain Behav Immun 2011;25:1367-75.
42. Neuser J, Knoop T. Sudden idiopathic hearing loss: psychopathology and antecedent stressful life-events. Br J Med Psychol 1986;59 (Pt 3):245-51.
43. Nakamura M, Aoki N, Nakashima T, et al. Smoking, alcohol, sleep and risk of idiopathic sudden deafness: a case-control study using pooled controls. J Epidemiol 2001;11:81-6.
44. Nakashima T, Tanabe T, Yanagita N, et al. Risk factors for sudden deafness: a case-control study. Auris Nasus Larynx 1997;24:265-70.
45. Kanzaki J. Sudden Deafness. Otorhinolaryngol Nova 1999;9:198-202.
46. Mattox DE, Simmons FB. Natural history of sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol 1977;86:463-80.
47. Suzuki S, Tanaka K, Suzuki N. Ambivalent aspects of interleukin-6 in cerebral ischemia: inflammatory versus neurotrophic aspects. J Cereb Blood Flow Metab 2009;29:464-79.
48. Kin H, Wang NP, Halkos ME, et al. Neutrophil depletion reduces myocardial apoptosis and attenuates NFkappaB activation/TNFalpha release after ischemia and reperfusion. J Surg Res 2006;135:170-8.
49. Wolters PJ, Wray C, Sutherland RE, et al. Neutrophil-derived IL-6 limits alveolar barrier disruption in experimental ventilator-induced lung injury. J Immunol 2009;182:8056-62.
50. Yamaguchi K, Itoh Y, Yokomizo C, et al. Blockade of IL-6 signaling exacerbates liver injury and suppresses antiapoptotic gene expression in methionine choline-deficient diet-Fed db/db mice. Lab Invest 2011;91:609-18.
51. Suwa T, Hogg JC, English D, et al. Interleukin-6 induces demargination of intravascular neutrophils and shortens their transit in marrow. Am J Physiol Heart Circ Physiol 2000;279:H2954-60.
52. Kimbrell MR, Warshakoon H, Cromer JR, et al. Comparison of the immunostimulatory and proinflammatory activities of candidate Gram-positive endotoxins, lipoteichoic acid, peptidoglycan, and lipopeptides, in murine and human cells. Immunol Lett 2008;118: 132-41.
53. Scheller J, Chalaris A, Schmidt-Arras D, et al. The pro- and antiinflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta 2011;1813:878-88.
54. Haubner F, Martin L, Steffens T, et al. The role of soluble adhesion molecules and cytokines in sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 2011;144:575-80.
55. Kanzaki J, Kanzaki S, Ogawa K. Long-term prognosis of steroiddependent sensorineural hearing loss. Audiol Neurootol 2009;14: 26-34.
56. Leonard BE. The concept of depression as a dysfunction of the immune system. Curr Immunol Rev 2010;6:205-12.
57. Brydon L, Walker C, Wawrzyniak A, et al. Synergistic effects of psychological and immune stressors on inflammatory cytokine and sickness responses in humans. Brain Behav Immun 2009;23:217-24.
58. Mazzeo RS, Donovan D, Fleshner M, et al. Interleukin-6 response to exercise and high-altitude exposure: influence of alpha-adrenergic blockade. J Appl Physiol 2001;91:2143-9.
59. Miller GE, Rohleder N, Cole SW. Chronic interpersonal stress predicts activation of pro- and anti-inflammatory signaling pathways 6 months later. Psychosom Med 2009;71:57-62.
60. Bierhaus A, Wolf J, Andrassy M, et al. A mechanism converting psychosocial stress into mononuclear cell activation. Proc Natl Acad Sci U S A 2003;100:1920-5.
61. Fauser C, Schimanski S, Wangemann P. Localization of beta1-adrenergic receptors in the cochlea and the vestibular labyrinth. J Membr Biol 2004;201:25-32.
62. Schimanski S, Scofield MA, Wangemann P. Functional beta2-adrenergic receptors are present in nonstrial tissues of the lateral wall in the gerbil cochlea. Audiol Neurootol 2001;6:124-31.
63. Khan KM, Sarfaraz N, Siddiqui S, et al. Immunohistochemical localization of G protein betagamma subunits in the lateral wall of the rat cochlea. J Anat 2006;208:205-18.
64. Khan KM, Sarfaraz N, Siddiqui S, et al. Expression of G protein alpha subunits in the lateral wall of the rat cochlea. J Anat 2003;202: 293-301.
65. Um JY, Jang CH, Kim KY, et al. Candidate genes of cerebrovascular disease and sudden sensorineural hearing loss. Clin Appl Thromb Hemost 2010;16:559-62.
66. Van Wijk F, Staecker H, Keithley E, et al. Local perfusion of the tumor necrosis factor alpha blocker infliximab to the inner ear improves autoimmune neurosensory hearing loss. Audiol Neurootol 2006;11:357-65.
67. Suslu N, Yilmaz T, Gursel B. Utility of anti-HSP 70, TNF-alpha, ESR, antinuclear antibody, and antiphospholipid antibodies in the diagnosis and treatment of sudden sensorineural hearing loss. Laryngoscope 2009;119:341-6.